Minimising the potential for metabolic activation in drug discovery

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.1, Iss.1, 2005-06, pp. : 91-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic Diseases Drug Discovery World Summit

By Liu Gang

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 577-582

Informa Healthcare

Access to resources Recommend Favorite

Metabolic Diseases Drug Discovery World Summit

By Sarabu Ramkanth

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1721-1726

Informa Healthcare

Access to resources Recommend Favorite

Metabolic activation in drug-induced liver injury

By Leung Louis Kalgutkar Amit S. Obach R. Scott

Drug Metabolism Reviews, Vol. 44, Iss. 1, 2012-02 ,pp. : 18-33

Informa Healthcare

Access to resources Recommend Favorite

The alluring potential of functionalized carbon nanotubes in drug discovery

By Ménard-Moyon Cécilia Venturelli Enrica Fabbro Chiara Samorì Cristian Da Ros Tatiana Kostarelos Kostas Prato Maurizio Bianco Alberto

Expert Opinion on Drug Discovery, Vol. 5, Iss. 7, 2010-07 ,pp. : 691-707

Informa Healthcare

Access to resources Recommend Favorite

Chimaeric G proteins: their potential use in drug discovery

By Milligan G. Rees S.

Trends in Pharmacological Sciences, Vol. 20, Iss. 3, 1999-03 ,pp. : 118-124

Elsevier

Access to resources Recommend Favorite